| Thalidomide: a role in oral oncology? |
| |
| 引用本文： | Porter SR,Jorge J. Thalidomide: a role in oral oncology?[J]. Oral oncology, 2002, 38(6): 527-531. DOI: 10.1016/S1368-8375(01)00114-2 |
| |
| 作者姓名： | Porter SR Jorge J |
| |
| 摘 要： | ![]()
|
| 收稿时间： | 2001-10-03 |
Thalidomide: a role in oral oncology? |
| |
| Porter S R,Jorge J. Thalidomide: a role in oral oncology?[J]. Oral oncology, 2002, 38(6): 527-531. DOI: 10.1016/S1368-8375(01)00114-2 |
| |
| Authors: | Porter S R Jorge J |
| |
| Affiliation: | Department of Oral Medicine, Eastman Dental Institute for Oral Health Care Sciences, UCL, University of London, 256 Gray's Inn Road, London, UK. |
| |
| Abstract: | ![]()
Thalidomide is having increasing application in the management of a wide spectrum of immunologically-mediated and infectious disorders. It is also suggested that this agent may also have be of importance in the treatment of solid and non-solid malignancies. The present article reviews the role of thalidomide in the management of malignancy and outlines its possible potential in the treatment of malignancy of the mouth. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ |
